Werner Baumann - 9 News
Tip: You can further refine your news selection by organizations.
Bayer: Slow start to the year as expected
Bayer Group business performance in the first quarter of 2023
11-May-2023 - The Bayer Group experienced a slow start to 2023 as expected. “Sales were on a par with the exceptionally strong prior-year quarter,” CEO Werner Baumann said on Thursday when presenting the Quarterly Statement for the first quarter. The normalization in the glyphosate business has accelerated, ...
Bayer: Significant growth in sales and earnings
Exceptionally strong performance at Crop Science
28-Feb-2023 - The Bayer Group achieved strong growth last year, posting significantly higher sales and earnings. “2022 was a very successful year for Bayer despite the challenging environment. We were able to deliver, even during these difficult times, and met the upgraded financial targets we set in August,” ...
Bill Anderson to become CEO of Bayer AG
09-Feb-2023 - The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson was elected unanimously after a thorough selection process which began mid last year. Werner ...
Bayer delivers robust performance despite pandemic
Foundation laid for future growth
26-Feb-2021 - The Bayer Group delivered robust operational performance in 2020. “Our operational strength in these turbulent times shows just how resilient our businesses are, even during the pandemic,” said Werner Baumann, Chairman of the Board of Management, on Thursday during the company’s Financial News ...
Bayer: Supervisory Board extends CEO Werner Baumann’s
Contract until the end of April 2024
14-Sep-2020 - The Supervisory Board of Bayer AG has unanimously decided to extend the contract of Werner Baumann, Chairman of the Board of Management, until April 30, 2024. Before the extension, Baumann’s contract would have expired at the 2021 Annual Stockholders’ Meeting. Baumann, 57, has worked for Bayer ...
Bayer: Encouraging business performance across all divisions
Agreements signed to divest Currenta and Animal Health
30-Oct-2019 - Bayer has made progress in all key areas and is on track both operationally and strategically. “Bayer had a successful third quarter,” Werner Baumann, Chairman of the Board of Management, said on Wednesday during the news conference call on the quarterly figures. “We increased the Group’s sales ...
Bayer completes biggest acquisition in its history
Group sales and earnings increase
05-Sep-2018 - Bayer successfully completed the biggest acquisition in its history in the second quarter of 2018, while operational performance improved, even without taking into account the newly acquired Monsanto business. Sales advanced at three of the four segments on a currency- and portfolio-adjusted ...
Bayer: Sales and earnings declined at both Consumer Health and Crop Science
Another record year for Pharmaceuticals
28-Feb-2018 - In 2017, Bayer’s operational business was at the prior-year level. The company made good progress strategically. “We took major steps toward the proposed acquisition of Monsanto,” Management Board Chairman Werner Baumann said on Wednesday at the Financial News Conference in Leverkusen. ...
Strong start to the year for Bayer
Growth momentum across all segments
28-Apr-2017 - The Bayer Group got off to a very successful start to 2017 and generated strong sales and earnings growth in the first quarter. “At Pharmaceuticals, we once again benefited from the very good performance of our key growth products,” CEO Werner Baumann said when he presented the interim report for ...
Haven't found the right news yet?
The chemeurope.com news search
Start your targeted search now with a wide range of filter options. Our database includes an archive of 24,996 chemistry news from business and science, which you can search by topic and organization, filtered by time and geography.